Open Collections

Protein kinase C activity of neutrophils in localized aggressive periodontitis

University of British Columbia

Localized Aggressive Periodontitis (LAP) is clinically characterized as a rapid, early onset bone loss around the first molars and incisors. Polymorphonuclear neutrophils (PMN) in LAP patients are hyperactive, generating excessive superoxide anions, cytokines, and enzymes, leading to host tissue injury. This hyper-responsive phenotype of LAP neutrophils suggests that the cells are somehow pre-activated, or primed in LAP, implicating the signaling molecules in the pathway for NADPH oxidase activation. Protein Kinase C has been identified as key molecule in the production of superoxide in neutrophils. In the first study, the role of PKC in priming of neutrophils from LAP patients was investigated. PKC activity was found to be higher in the membranes of neutrophils from LAP patients than healthy subjects, suggesting translocation of the enzyme from the cytosol to the membrane. Analysis of five PKC isoforms indicated that at rest, phosphorylated PKC β1, ξ, and δ, and from LAP subjects were expressed at higher levels than of those from healthy subjects. There were no differences in the expression of PKC isoform transcripts between healthy and LAP groups, indicating that the increase in PKC is not a result of increased transcription. Expression of p47phox phosphorylation was enhanced in neutrophils from subjects with LAP, supporting our findings that the neutrophils are indeed primed. Inhibition studies, using PKC inhibitors, demonstrated a greater inhibition of superoxide production in neutrophils from healthy subjects than those subjects with LAP. Application of classical and zeta PKC inhibitors demonstrated greater superoxide inhibition than the use of beta and delta inhibitors. In the latter half of the study, whole cell neutrophil lysates from healthy and LAP groups pre treated with RvE1 were analyzed for phosphorylated PKC isoforms. In the healthy group, RvE1 did not inhibit phosphorylation of any PKC isoforms. However, in the LAP group, RvE1 reduced the phosphorylation of PKC ô and compared to PBS-treated neutrophils. Similarly, RvEI only reduced phosphorylation of p47PiX in neutrophils from LAP subjects. Pharmacologically induced dephosphorylation with RvE1 returns LAP PMN to a normal neutrophil phenotype. RvE1 is a potential therapeutic modality for the treatment of the periodontal lesions associated with LAP.

Thesis/Dissertation

application/pdf

2009-03-09

Attribution-NonCommercial-NoDerivatives 4.0 International

http://hdl.handle.net/2429/5738

Dental Science

University of British Columbia

UBCV

http://creativecommons.org/licenses/by-nc-nd/4.0/